SavedAdd your journal

Journals / Turkish Journal of Medical Sciences / 2014 / Cilt: 44 - Sayı: 4

The comparison of folate and vitamin B12 levels between depressive and nondepressive postmenopausal women

Özlem ŞENGÜL
Dilek UYGUR
Mustafa GÜLEÇ
Berna DİLBAZ
Esma Meltem ŞİMŞEK
Ümit GÖKTOLGA
Pages
611–615
Publication Date
2014-05-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Supplementation of folic acid and vitamin B12 for postmenopausal women does not seem to be an effective intervention to reduce depressive symptoms.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:To investigate if there is any association between the serum folate and vitamin B12 status and the depressive symptoms in postmenopausal women.
📊
Key Findings & Data:Materials and methods: The study included 95 postmenopausal women.
💡
Conclusion & Impact:Supplementation of folic acid and vitamin B12 for postmenopausal women does not seem to be an effective intervention to reduce depressive symptoms.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Key words: Depressive symptoms · folate · menopause

Abstract

To investigate if there is any association between the serum folate and vitamin B12 status and the depressive symptoms in postmenopausal women. Materials and methods: The study included 95 postmenopausal women. The Center for Epidemiologic Studies Depression Scale (CES-D) was used to assess their depressive symptoms. The investigated women were classified into 2 groups based on the existence of depressive symptoms. These 2 groups were compared in terms of folic acid and vitamin B12 levels. Results: Among 95 cases, 27 postmenopausal women scored 16 or more on the CES-D scale and were classified as the depressive group (Group 1), and 68 postmenopausal women scored 15 or less and were classified as the nondepressive group (Group 2). The serum levels of folate were 11.5 ± 5.4 ng/mL in group 1 and 12.3 ± 5.3 ng/mL in group 2. The concentrations of vitamin B12 were 456.2 ± 343.4 pg/mL in group 1 and 446.5 ± 165.1 pg/mL in group 2. The folate and vitamin B12 levels did not significantly correlate to the frequency of depressive symptoms (P = 0.52 and P = 0.24, respectively). Conclusion: In this study, no correlation was detected between serum folate and vitamin B12 levels and depressive symptoms in postmenopausal women. Supplementation of folic acid and vitamin B12 for postmenopausal women does not seem to be an effective intervention to reduce depressive symptoms.

Özet

To investigate if there is any association between the serum folate and vitamin B12 status and the depressive symptoms in postmenopausal women. Materials and methods: The study included 95 postmenopausal women. The Center for Epidemiologic Studies Depression Scale (CES-D) was used to assess their depressive symptoms. The investigated women were classified into 2 groups based on the existence of depressive symptoms. These 2 groups were compared in terms of folic acid and vitamin B12 levels. Results: Among 95 cases, 27 postmenopausal women scored 16 or more on the CES-D scale and were classified as the depressive group (Group 1), and 68 postmenopausal women scored 15 or less and were classified as the nondepressive group (Group 2). The serum levels of folate were 11.5 ± 5.4 ng/mL in group 1 and 12.3 ± 5.3 ng/mL in group 2. The concentrations of vitamin B12 were 456.2 ± 343.4 pg/mL in group 1 and 446.5 ± 165.1 pg/mL in group 2. The folate and vitamin B12 levels did not significantly correlate to the frequency of depressive symptoms (P = 0.52 and P = 0.24, respectively). Conclusion: In this study, no correlation was detected between serum folate and vitamin B12 levels and depressive symptoms in postmenopausal women. Supplementation of folic acid and vitamin B12 for postmenopausal women does not seem to be an effective intervention to reduce depressive symptoms.

🔖

Cite This Article

ŞENGÜL, Ö., UYGUR, D., GÜLEÇ, M., DİLBAZ, B., ŞİMŞEK, E. M., GÖKTOLGA, Ü. (2014). The comparison of folate and vitamin B12 levels between depressive and nondepressive postmenopausal women. Turkish Journal of Medical Sciences, Cilt: 44 - Sayı: 4, 611–615. https://ajindex.com/articles/220659

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Gracia CR, Freeman EW, Sammel MD, Lin H, Mogul M. Hormones and sexuality during transition to menopause. Obstet Gynecol 2007; 109: 831–840.
  2. Leung BM, Kaplan BJ. Perinatal depression prevalence, risks, and the nutrition link—a review of the literature. J Am Diet Assoc 2009; 109: 1566–1575.
  3. Herrmann W, Obeid R. Biomarkers of folate and vitamin B(12) status in cerebrospinal fluid. Clin Chem Lab Med 2007; 45: 1614–1620. Słopiena R, Jasniewicz K, Meczekalski B, WarenikSzymankiewicz A, Lianeri M, Jagodzinski PP. Polymorphic variants of genes encoding MTHFR, MTR, and MTHFD1 and the risk of depression in postmenopausal women in Poland. Maturitas 2008; 61: 252–255.
  4. Fava M, Mischoulon D. Evidence for folate in combination with antidepressants at initiation of therapy. J Clin Psychiatry 2010; 71: e Miller AL. The methylation, neurotransmitter, and antioxidant connections between folate and depression. Altern Med Rev 2008; 13: 216–226.
  5. Clarke R, Smith AD, Jobst KA, Refsum H, Sutton L, Ueland PM. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 1998; 55: 1449–1455. Tiemeier H, van Tuijl HR, Hofman A, Meijer J, Kiliaan AJ, Breteler MM. Vitamin B12, folate, and homocysteine in depression: The Rotterdam Study. Am J Psychiatry 2002; 159: 2099–2101. Nanri A. Nutritional epidemiology of type 2 diabetes and depressive symptoms. J Epidemiol 2013; 23: 243–250. Radloff LS. The CES-D scale: A self-report depression scale for research in the general population. Appl Psychol Meas 1997; 1: 385–401. Freeman EW. Associations of depression with the transition to menopause. Menopause 2010; 17: 823–827.
  6. Bromberger JT, Matthews KA, Schott LL, Brockwell S, Avis NE, Kravitz HM, Everson-Rose SA, Gold EB, Sowers M, Randolph JF Jr. Depressive symptoms during the menopausal transition: The Study of Women’s Health Across the Nation (SWAN). J Affect Disord 2007; 103: 267–272.
  7. Beydoun MA, Kuczmarski MT, Beydoun HA, Shroff MR, Mason MA, Evans MK, Zonderman AB. The sex-specific role of plasma folate in mediating the association of dietary quality with depression symptoms. J Nutr 2009; 140: 338–348. Bottiglieri T. Homocysteine and folate metabolism in depression. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29: 1103– 1 D’Anci KE, Rosenberg IH. Folate and brain function in the elderly. Curr Opin Clin Nutr Metab Care. 2004; 7: 659–664.
  8. Bottiglieri T, Laundy M, Crellin R, Toone BK, Carney MW, Reynolds EH. Homocysteine, folate, methylation, and monoa